BMP2K and neoplasm: Seven days post tumor engraftment, tumor-bearing mice were injected intracranially with either PBS (Control), NK cells, NK cells with sdCD16 (NK Cells + sdCD16), or NK cells with BiKE molecule (NK Cells + BiKE).